Clinical Trial Update: Combination Chemotherapy and Ponatinib Hydrochloride in Treating Patients With Acute Lymphoblastic Leukemia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ponatinib in combination with chemotherapy for acute lymphoblastic leukemia and BCR-ABL1-positive leukemias, including accelerated and …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Chronic Myeloid Leukemia Accelerated Phase
• Chronic Myeloid Leukemia Blast Phase

Drugs mentioned

• Ponatinib (ponatinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia | Phase 2 | Status: ACTIVE_NOT_RECRUITING